Israel Active

20-year-old Kalim was sent home from hospital to die in St Petersburg after doctors said they could not treat his acute lymphoblastic leukemia. He immigrated to Israel where five months of CAR-T treatment at Rambam Health Care Campus gave Kalim back his life.

A nationwide study led by Jerusalem’s Hadassah hospital discovered that pregnant women brought into the Intensive Care Unit seriously ill with Covid-19, were more likely to improve if they gave birth (by Caesarian section) before their condition deteriorated. The data will save many lives.

The Nerivio device from Israeli startup Theranica (see previously) already has US FDA approval to treat acute migraines. It has now been approved for preventing migraines. Recent trials of 248 participants showed a huge improvement for those using Nerivio compared to those on a placebo device.

The US FDA has granted marketing authorization to the PMD-200 monitor developed by Israel’s Medasense Biometrics (see previously). The device monitors pain in non-communicating (e.g., anaesthetized) patients and already has made an impact in multiple countries.

Israel’s Protai has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level. It can identify which patients will respond to a given treatment, as well as identifying identify diseases that a therapy should be able to treat.

Delray Medical Center is the first hospital in Florida to treat an Alzheimer’s disease patient using non-invasive focused ultrasound technology from Israel’s Insightec. The FDA-approved clinical trial will test reducing excessive protein buildup to open the blood-brain barrier.

Israel’s LDS Biotech has developed the Lyotropic treatment delivery system. Medications can be applied directly to the problem area without causing damage to organs such as the liver. It was successful in compassionate use and clinical (human) trials are being planned.

Researchers at Israel’s Ben-Gurion University found a new approach for treating Alzheimer’s disease. They developed a new molecule VBIT-4 that prevents the over-expression of the protein VDAC1, which controls mitochondrial activity and cell life and death.

Israel’s SenterCare claims to have the only unobstructive technology that can differentiate between people in the same home. It notifies about safety incidents, with AI to predict falls and recommend interventions. Its aim is to preserve and prolong the senior’s quality of life and reduce health costs.

Several Israeli startups are involved in helping people to live longer. Longevity.AI has developed a comprehensive system for hospitals, health funds, and other medical organizations that allows them to track and monitor the health of their patients in real-time. It says it is never too early to grow younger.